📍 WASHINGTON D.C., USA
31.10.2026
FDA Faces Unprecedented Legal Hurdles in Effort to Rescind Approval for Autoimmune Drug Tavneos
The United States Food and Drug Administration is navigating a complex administrative and legal dispute as it attempts to revoke marketing authorization for Tavneos, an autoimmune therapeutic approved to treat rare syste...